CSRXP: FINALIZED CMS COVERAGE DECISION FOR ADUHELM PROTECTS SENIORS AND TAXPAYERS FROM BIG PHARMA PRICE-GOUGING

04-8-2022 Press Release

Decision Appropriately Balances Access to Treatment with the Need for More Data on the Clinical Value for Patients Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in reaction to the finalized National Coverage Determination decision for monoclonal antibodies for the treatment of Alzheimer’s from the U.S. Centers for Medicare & […]

CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING DRUG PRICES, CONGRESS MUST ACT

03-2-2022 Press Release

Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable Following Another State of the Union Call for Action Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to President Biden once again calling for Congress to advance solutions to lower out-of-control drug prices and hold Big Pharma […]

CSRXP STATEMENT ON CONFIRMATION OF DR. ROBERT CALIFF AS COMMISSIONER OF U.S. FOOD AND DRUG ADMINISTRATION

02-15-2022 Press Release

FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting Competition, Transparency and Value Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the U.S. Senate confirmation of Dr. Robert M. Califf to serve as commissioner of the U.S. Food and Drug Administration (FDA). “CSRxP congratulates Dr. Califf […]

CSRXP POLL: VOTERS SEE THROUGH BIG PHARMA’S BLAME GAME, WANT WASHINGTON TO LOWER DRUG PRICES & HOLD DRUG COMPANIES ACCOUNTABLE

02-7-2022 Press Release

Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control Drug Prices and Support Market-Based Solutions to Boost Affordability, Competition and Value Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey conducted by Morning Consult today. “Voters overwhelmingly view out-of-control prescription drug prices as a top political issue in […]

CSRXP: BIG PHARMA’S BUSINESS-AS-USUAL APPROACH TO JANUARY PRICE HIKES UNDERSCORES URGENCY FOR RX SOLUTIONS

02-2-2022 Press Release

Drug Companies Increased Prices on 785 Brand Name Products in First Month of 2022 Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today reacting to pharmaceutical industry price hikes on 785 brand name drugs in the first month of 2022 by an average of 4.9 percent. “Throughout the COVID-19 pandemic, Big Pharma […]

CSRXP STATEMENT AHEAD OF COMMITTEE VOTE FOR DR. ROBERT CALIFF TO LEAD U.S. FOOD AND DRUG ADMINISTRATION

01-12-2022 Press Release

Next FDA Commissioner Must Promote Competition, Transparency And Value In The Pharmaceutical Marketplace Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today ahead of a U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) executive session to consider the nomination of Dr. Robert M. Califf to serve as commissioner of the […]

HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 400 BRAND NAME DRUGS TO RING IN 2022

01-3-2022 Press Release

Fourth Major Round Of Pandemic Price Hikes Highlight Urgency for Policymakers to Hold Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today reacting to Big Pharma increasing prices on 434 brand name drugs in just the first few days of 2022 — as part of biennial, traditional price hikes. […]

CSRXP: LANDMARK OVERSIGHT REPORT DEBUNKS BIG PHARMA’S FALSE RHETORIC, ADDS TO MOMENTUM TO LOWER RX PRICES

12-10-2021 Press Release

U.S. House Oversight & Reform Committee Report Finds Big Pharma’s Pricing Practices Are “Unsustainable, Unjustifiable and Unfair”  Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to a new report from the U.S. House Committee on Oversight and Reform examining Big Pharma’s pricing and business practices. “CSRxP applauds […]

CSRxP: U.S. House Adds to Unprecedented Momentum to Hold Big Pharma Accountable with Passage of Rx Solutions in Build Back Better

11-19-2021 Press Release

Congress Must Capitalize on Historic Opportunity to Lower Drug Prices, Reject Pharma-Backed Policies That Would Hike Health Care Premiums Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to the U.S. House passage of drug pricing provisions contained in the Build Back Better Act. “CSRxP applauds House lawmakers […]

CSRXP: BIG PHARMA’S EGREGIOUS PRICING OF UNPROVEN ALZHEIMER’S TREATMENT DRIVES HIGHER PREMIUMS FOR SENIORS

11-12-2021 Press Release

Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical Benefit Will Cost Medicare Part B Outpatients $21.60 More Per Month Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on news that Medicare Part B premiums for outpatient beneficiaries will increase by $21.60 next year. According to Bloomberg Government, “Medicare […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.